MicroRNA-7 functions as a tumor-suppressor gene by regulating ILF2 in pancreatic carcinoma

Yiliang Bi1, Wei Shen1, Min Min1

  • 1Department of Gastroenterology, 307 Hospital of PLA, Academy of Military Medical Science, Beijing 100071, P.R. China.

Insights

Interleukin enhancer binding factor 2 (ILF2) acts as an oncogene in pancreatic cancer, driving epithelial-mesenchymal transition. MicroRNA-7 suppresses ILF2, and curcumin treatment boosts miR-7, inhibiting ILF2 and offering therapeutic potential.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Interleukin enhancer binding factor 2 (ILF2) is upregulated in pancreatic carcinoma and implicated in its pathogenesis.
  • The regulatory mechanisms of ILF2 in pancreatic cancer are not well understood.
  • ILF2 may represent a potential therapeutic target for pancreatic cancer.

Purpose of the Study:

  • To investigate the role of ILF2 in pancreatic carcinoma PANC-1 cells.
  • To explore the regulatory relationship between ILF2, microRNA-7 (miR-7), and epithelial-mesenchymal transition (EMT).
  • To assess the effect of curcumin on ILF2 and miR-7 expression in pancreatic cancer cells.

Main Methods:

  • Cell culture of pancreatic carcinoma PANC-1 cells.
  • Analysis of ILF2 gene and protein expression.
  • Investigation of miR-7's regulatory effect on ILF2.
  • Assessment of EMT-associated gene regulation by ILF2 and miR-7.
  • Treatment of cells with curcumin and evaluation of its impact on miR-7 and ILF2 levels.

Main Results:

  • ILF2 functions as an oncogene in PANC-1 cells, regulating EMT-associated genes.
  • miR-7 suppresses ILF2 mRNA and protein expression in PANC-1 cells.
  • miR-7 acts as a tumor suppressor, negatively regulating EMT-associated genes.
  • Curcumin treatment increases miR-7 expression and decreases ILF2 protein levels.
  • ILF2 is identified as a downstream target of curcumin.

Conclusions:

  • ILF2 is regulated by miR-7 in pancreatic carcinoma.
  • Downregulation of miR-7 may contribute to ILF2 overexpression in pancreatic cancer.
  • Curcumin demonstrates potential therapeutic value by modulating the miR-7/ILF2 axis and inhibiting EMT.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.1K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.0K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.2K